Glial fibrillary acidic protein is pathologically modified in Alexander disease
Journal of Biological Chemistry · 2024
DOI: 10.1016/j.jbc.2024.107402 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2024. Verfasst von Ni-Hsuan Lin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular Medicine, National Tsing Hua University, Hsinchu, Taiwan. Hauptthemen laut MEDLINE: Alexander Disease, Glial Fibrillary Acidic Protein, Ubiquitination. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS.
Abstract (Originalsprache)
Here, we describe pathological events potentially involved in the disease pathogenesis of Alexander disease (AxD). This is a primary genetic disorder of astrocyte caused by dominant gain-of-function mutations in the gene coding for an intermediate filament protein glial fibrillary acidic protein (GFAP). Pathologically, this disease is characterized by the upregulation of GFAP and its accumulation as Rosenthal fibers. Although the genetic basis linking GFAP mutations with Alexander disease has been firmly established, the initiating events that promote GFAP accumulation and the role of Rosenthal fibers (RFs) in the disease process remain unknown. Here, we investigate the hypothesis that disease-associated mutations promote GFAP aggregation through aberrant posttranslational modifications. We found high molecular weight GFAP species in the RFs of AxD brains, indicating abnormal GFAP crosslinking as a prominent pathological feature of this disease. In vitro and cell-based studies demonstrate that cystine-generating mutations promote GFAP crosslinking by cysteine-dependent oxidation, resulting in defective GFAP assembly and decreased filament solubility. Moreover, we found GFAP was ubiquitinated in RFs of AxD patients and rodent models, supporting this modification as a critical factor linked to GFAP aggregation. Finally, we found that arginine could increase the solubility of aggregation-prone mutant GFAP by decreasing its ubiquitination and aggregation. Our study suggests a series of pathogenic events leading to AxD, involving interplay between GFAP aggregation and abnormal modifications by GFAP ubiquitination and oxidation. More important, our findings provide a basis for investigating new strategies to treat AxD by targeting abnormal GFAP modifications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Molecular Medicine, National Tsing Hua University, Hsinchu, Taiwan.
- Department of Cell Biology and Physiology, University of North Carolina, Chapel Hill, North Carolina, USA.
- Institute of Molecular Medicine, National Tsing Hua University, Hsinchu, Taiwan; School of Medicine, College of Life Sciences and Medicine, National Tsing Hua University, Hsinchu, Taiwan. Electronic address: mdperng@lif…
Förderung
- NINDS NIH HHS
Zitieren
APA
Lin, N. H., Jian, W. S., Snider, N., & Perng, M. D. (2024). Glial fibrillary acidic protein is pathologically modified in Alexander disease. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2024.107402
Vancouver
Lin NH, Jian WS, Snider N, Perng MD. Glial fibrillary acidic protein is pathologically modified in Alexander disease. Journal of Biological Chemistry. 2024. doi:10.1016/j.jbc.2024.107402
BibTeX
@article{Lin2024,
author = {Lin, Ni-Hsuan and Jian, Wan-Syuan and Snider, Natasha and Perng, Ming-Der},
title = {Glial fibrillary acidic protein is pathologically modified in Alexander disease},
journal = {Journal of Biological Chemistry},
year = {2024},
doi = {10.1016/j.jbc.2024.107402}
}
EUVIMED